Tenax Therapeutics, Inc.

Tenax Therapeutics, Inc.

1.36
EUR
0.00
(0.00%)
-1.22EPS
Apr 01Next Earn

Important Dates

Tenax Therapeutics, Inc.'s next confirmed earnings release is scheduled for April 1, 2027.

Earnings Date4/1/2027

Share Statistics

As of September 30, 2026, Tenax Therapeutics, Inc. has 45.54M shares outstanding.

Shares Outstanding45.54M

Financial Position

As of September 30, 2026, Tenax Therapeutics, Inc. maintains a current ratio of 14.01, meaning it holds 14.0x the short-term assets needed to cover near-term liabilities.

Current Ratio14.01
Quick Ratio13.61

Financial Efficiency

Over the twelve months ended September 30, 2026, Tenax Therapeutics, Inc. posted a negative return on equity (ROE) of -64.20, meaning shareholder capital produced losses rather than profits. Return on assets (ROA) is negative at -59.83, reflecting losses generated across the asset base. The company generates approximately - - in revenue per employee across its workforce of 16.00, a quick read on workforce productivity versus industry peers.

Return on Equity (ROE)-64.20
Return on Assets (ROA)-59.83
Employee Count16.00

Income Statement

EUR

Over the twelve months ended September 30, 2026, Tenax Therapeutics, Inc. generated - - in revenue and converted that into -58.02M in net income, yielding earnings per share of -1.22. EBITDA reached -61.35M, while operating income came in at -61.35M.

Operating Income-61.35M
Pretax Income-58.02M
Net Income-58.02M
EBITDA-61.35M
EBIT-61.35M
Earnings Per Share (EPS)-1.22

Balance Sheet

EUR

These figures are as of September 30, 2026. Total book value stands at 95.87M, with working capital of 95.87M providing operational flexibility.

Cash & Cash Equivalents100.34M
Net Debt-100.34M
Equity (Book Value)95.87M
Book Value Per Share2.11
Working Capital95.87M

Cash Flow

EUR

Tenax Therapeutics, Inc. produced -43.54M in operating cash flow over the twelve months ended September 30, 2026.

Operating Cash Flow-43.54M
Free Cash Flow-43.54M
FCF Per Share-0.91

Stock Splits

Tenax Therapeutics, Inc.'s most recent stock split took place on January 3, 2024 with a 80:1 split ratio.

Last Split Date1/3/2024
Split Ratio80:1